EJMK Ventures’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
EJMK Ventures's BMY Position: Q3 2026 in Review
EJMK Ventures opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,473 shares worth $217K. The stake represents 0.09% of the portfolio and ranks #157 among its holdings. This is a return to the name: EJMK Ventures previously reported a position in BMY as recently as Q1 2026.
EJMK Ventures first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $249K in Q4 2025. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- EJMK Ventures held 3,473 shares of Bristol-Myers Squibb worth $217K as of Q3 2026.
- Bristol-Myers Squibb was a new EJMK Ventures position in Q3 2026.
- Bristol-Myers Squibb made up 0.09% of EJMK Ventures's portfolio in Q3 2026, its #157 holding.
- EJMK Ventures first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- EJMK Ventures's Bristol-Myers Squibb position peaked at $249K in Q4 2025.
- 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.